Front Page
June 2, 2026
UW Medicine News: ADAI Participating in a National Study of a GLP-1 for Alcohol Use Disorder
Associate Professor Mary Hatch, PhD, is leading a site at ADAI for a national clinical trial investigating the use of a GLP-1/GIP drug called brenipatide for the treatment of alcohol use disorder. The study was written up in UW Medicine News today by Brian Donohue. The study, RENEW-ALC, is a 14-month, two-stage trial. In the…
ADAI Lunch & Learn: Increasing Resilience from Alcohol Harm: Gender-Affirming & Inclusive Healthcare (June 26, 12pm PT)
Join ADAI and presenter Jessica Canning, PhD, of the UW Center for the Study of Health and Risk Behaviors (CSHRB) and Seven Directions, for our next virtual Lunch & Learn session, June 26, 2026, 12-1pm PT! Transgender and nonbinary adults are disproportionately impacted by harm from alcohol use, and these disparities are compounded for trans…
June 1, 2026
Webinar: Washington State Community Drug Checking Network (CDCN) – June 11, 1pm PT
The Washington State Community Drug Checking Network (CDCN) is a partnership of organizations that provide community-level drug checking (offering people who use drugs information about what’s in their drugs) and related harm reduction services. This webinar, presented in partnership with UW ADAI, will cover: Register for the CDCN webinar here!
May 29, 2026
RECORDING AVAILABLE: Executive Function and Communication in Early Adulthood in the Context of FASD (ADAI Lunch & Learn)
Sara Kover, PhD, of the UW Department of Speech & Hearing Sciences, joined ADAI for our May 2026 Lunch & Learn webinar. The recording from this session is now available! Dr. Kover’s presentation explored preliminary findings from a project designed to understand the values and experiences of individuals with FASD and their families during a…
LISTEN: KUOW’s “Ask a Doctor” Episode About Ketamine Features ADAI’s Nathan Sackett, MD, MS
Nathan Sackett, MD, MS, Director of the Center for Novel Therapeutics in Addiction Psychiatry at ADAI, was interviewed this week by KUOW for their “Ask a Doctor” series. Dr. Sackett’s work focuses on the intersection between substance use and psychiatric disorders and the therapeutic use of psychedelics for addiction. In the interview, he talks to…
May 14, 2026
ADAI/CEDEER Virtual Conference: Supporting the Health of People Who Use Drugs, June 2-3, 2026
Join ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) to learn more about practical strategies and programs that support the health of people who use drugs in Washington State. Topics for this event will include: Learn from experts from WA DOH, Clallam County Public Health, Capitol Hill Pharmacy, Bloom Psychiatry, Harborview, Public Health-Seattle & King…
May 4, 2026
Northwest ATTC Webinar: Direct to Inject (Buprenorphine) Strategies to Improve Care for People with SUD and Infectious Disease (May 20, 12pm PT)
Join the Northwest ATTC on May 20, 2026 (12-1pm PT) for their next webinar: Syndemic Care for People Struggling with Substance Use Disorder (SUD) – Leveraging Direct to Inject (DTI) Strategies to Improve Care Integration Presenter: Chris Bositis, MD, Clinical Director, UCSF National Clinician Consultation Center (NCCC) In spite of recent gains made in reducing new…
May 1, 2026
The Northwest ATTC at ADAI is Hiring! Continuing Education Specialist 4 (80% FTE, fully remote)
Come join our awesome team and help the Northwest Addiction Technology Transfer Center (Northwest ATTC) help others in the addiction workforce! The Northwest ATTC is seeking a Continuing Education Specialist 4 (80% FTE, pay range $81,780-$122,676). This is a FULLY REMOTE position that may include the opportunity for some travel. Minimum requirements include a Master’s degree and 3 years of…
April 16, 2026
RECORDING AVAILABLE: Results from the 2025 WA State Syringe Services Program Health Survey – Report and Webinar
The WA State Syringe Services Program Health Survey is conducted every other year by CEDEER at UW ADAI in partnership with Public Health-Seattle & King County, the Washington State Department of Health, and syringe services programs (SSPs) across the state. The surveys asks participants about their substance use, health behaviors, and health care and substance use treatment needs….
April 7, 2026
ADAI Lunch & Learn: Motivated Cannabis Compliance: Using Retail Incentives to Sell Safety (April 30, 12pm PT)
In this month’s ADAI Lunch & Learn, Sarah Okey, PhD, Research Psychologist & Research Program Manager at the WA State Liquor and Cannabis Board, will showcase how the retail point-of-sale is one of the most critical interventions for consumer safety. Over 90% of adults who buy cannabis at Washington retail stores ask staff questions about what…
Next page
